Health Affairs, 25, no. 2 (2006): 491-500 doi: 10.1377/hlthaff.25.2.491 © 2006 by Project HOPE	New Online   McAllen, TX & Beyond: An Expert Roundtable   Geography & Reform   Medicaid or Insurance Exchange?   Siren Song of New GME   Public Plan Option: Pro & Con

This Article Full Text (HTML) Reprint (PDF) Submit a response to this article Alert me when this article is cited Alert me when Comments are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (5) Citing Articles via Google Scholar Google Scholar Articles by Morden, N. E. Articles by Garrison, L. P. Search for Related Content PubMed PubMed Citation Articles by Morden, N. E. Articles by Garrison, L. P., Jr. Related Collections Access To Care Health Promotion/Disease Prevention Health Reform Legal/Regulatory Issues Medicare Business Of Health Mental Health/Substance Abuse Pharmaceuticals Consumer Issues Elderly

DataWatch

Implications Of Part D For Mentally Ill Dual Eligibles: A Challenge For Medicare

Through the Part D drug program, Medicare has assumed responsibility for the prescription drug needs of beneficiaries and, consequently, for an important component of mental health treatment: psychotropic drugs. Managing the prescription drug benefits of mentally ill dual eligibles could challenge this new program. Efforts to balance quality assurance and cost-effectiveness will be complicated by this population’s vulnerability and high level of health care need, the uncertainties surrounding optimal psychotropic drug use, and the economic incentives of prescription-only insurers. We discuss the details and policy implications of this challenge.

                      What's this?

This article has been cited by other articles:

				J. M. Donohue, H. A. Huskamp, and S. H. Zuvekas Dual Eligibles With Mental Disorders And Medicare Part D: How Are They Faring? Health Aff., May 1, 2009; 28(3): 746 - 759. [Abstract] [Full Text] [PDF]

				K. Jones, C. Siegel, D. N. Bertollo, and J. Samuels Impact of the Medicare Modernization Act on Dually Eligible Persons With Psychiatric Diagnoses: A New York State Case Study Psychiatr Serv, April 1, 2009; 60(4): 512 - 519. [Abstract] [Full Text] [PDF]

				H. Chen, A. Nwangwu, R. Aparasu, E. Essien, S. Sun, and K. Lee The Impact of Medicare Part D on Psychotropic Utilization and Financial Burden for Community-Based Seniors Psychiatr Serv, October 1, 2008; 59(10): 1191 - 1197. [Abstract] [Full Text] [PDF]

				J. M. Donohue and R. G. Frank Estimating Medicare Part D's Impact on Medication Access Among Dually Eligible Beneficiaries With Mental Disorders Psychiatr Serv, October 1, 2007; 58(10): 1285 - 1291. [Abstract] [Full Text] [PDF]

				J. M. Rosenberg Overview of Medicare Part D prescription drug benefit: Potential implications for patients with psychotic disorders Am. J. Health Syst. Pharm., January 15, 2007; 64(2_Supplement_1): S18 - S23. [Abstract] [Full Text] [PDF]